EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Review on natural killer/T‐cell lymphoma

Xiaohua He, Yan Gao, Zhiming Li iD, Huiqiang Huang

Hematological Oncology · 2023-04 · 41 (2) · 221-229

DOI: 10.1002/hon.2944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematological Oncology, online erschienen am 09.12.2021. Verfasst von Xiaohua He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen Uni…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Lymphoma, Extranodal NK-T-Cell. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Guangzhou Science and Technology Project, National Science and Technology Major Project, Sun Yat-sen University Cancer Center Clinical Research 308 Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extranodal natural killer (NK)/T‐cell lymphoma (ENKTL) is strongly associated with Epstein–Barr virus (EBV) and has a high prevalence in Asian and in Central and South America. About 85% of ENKTLs derive from NK cells and 15% from T‐cells. Various factors have been implicated in the development of ENKTL. Molecular pathogenesis of NK/T‐cell lymphomas include mutations of genes, involving in the Janus Kinase/signal transducer and activator of transcription pathway, RNA helicase family, epigenetic regulation, and tumor suppression. The relationship between ENKTL and human leukocyte antigen has been demonstrated. Radiotherapy plays a key role in the first‐line treatment of early‐stage. In stage III/IV diseases, non‐anthracycline‐regimens‐containing L‐asparaginase are recommended. Although clinical remission after L‐asparaginase‐based combination therapy has been achieved in the majority of patients with advanced‐stage or relapsed/refractory extranodal NK/T‐cell lymphoma‐nasal type, the long‐term overall survival is still poor. Recently, immunotherapy and new therapeutic targets have gained much attention. In this article, we discuss the pathogenesis, diagnosis, prognostic models and management options of ENKTL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsLymphoma, Extranodal NK-T-CellHumansAsparaginaseEpigenesis, GeneticHerpesvirus 4, HumanKiller Cells, Natural

Stichwörter der Autor:innen

EBVL-asparaginaseNK/T-cell lymphomaPD-1chidamidegene mutationhuman leukocyte antigenprognostic models

Substanzen

Asparaginase

Autor:innen und Institutionen

  • Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.

ORCID-Profile: Zhiming Li

Förderung

  • Guangzhou Science and Technology Project
  • National Science and Technology Major Project
  • Sun Yat-sen University Cancer Center Clinical Research 308 Program
  • National Natural Science Foundation of China

Zitieren

APA

He, X., Gao, Y., Li, Z., & Huang, H. (2023). Review on natural killer/T‐cell lymphoma. Hematological Oncology, 41(2), 221-229. https://doi.org/10.1002/hon.2944

Vancouver

He X, Gao Y, Li Z, Huang H. Review on natural killer/T‐cell lymphoma. Hematological Oncology. 2023;41(2):221-229. doi:10.1002/hon.2944

BibTeX
@article{He2023,
  author = {He, Xiaohua and Gao, Yan and Li, Zhiming and Huang, Huiqiang},
  title = {Review on natural killer/T‐cell lymphoma},
  journal = {Hematological Oncology},
  year = {2023},
  volume = {41},
  number = {2},
  pages = {221--229},
  doi = {10.1002/hon.2944}
}
Kostenlos starten →